Neural Analytics Inc. Announces The Appointment Of Dr. Neil A. Martin As Chief Medical Officer

LOS ANGELES--(BUSINESS WIRE)--Neural Analytics, a medical device company focusing on developing devices and services to measure, diagnose and track brain health and concussions, announced the appointment of Dr. Neil A. Martin as chief medical officer.

As the chairman and W. Eugene Stern Professor in Neurosurgery in the UCLA Department of Neurosurgery, Dr. Martin comes to Neural Analytics with extensive experience in research and treatment of brain injury and neurovascular disorders, including aneurysm, stroke and arteriovenous malformation.

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.